Clinical Trial Update: Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

View source ↗

Summary

This clinical trial is recruiting real-world patients with non-small cell lung cancer to evaluate neoadjuvant chemo-immunotherapy in individuals who do not unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sheba Medical Center | Conditions: Stage II-III Non-small Cell Lung Cancer | Status: RECRUITING